Vaccibody AS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Vaccibody AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10934
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ノルウェー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vaccibody AS (Vaccibody) is a vaccine company that provides discovery and development of novel immunotherapies, prophylactic and therapeutic vaccines. The company develops VB10.16, a DNA based immunotherapy targeting malignancies caused by human papilloma virus. It conducts exploratory safety and immunogenicity studies for HPV16+ immunotherapy VB10.16 in women with high grade intraepithelial neoplasia. Vaccibody provides vaccines against human papilloma virus induced cancer, melanoma, prostate cancer, B cell lymphoma, multiple myeloma, influenza, herpes simplex virus 2, HIV and tuberculosis. The company partners with academic and pharmaceutical companies. Vaccibody is headquartered in Oslo, Norway.

Vaccibody AS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Vaccibody AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vaccibody AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Vaccibody AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vaccibody AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Vaccibody AS, Medical Devices Deals, 2012 to YTD 2018 9
Vaccibody AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Vaccibody AS, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Vaccibody Raises USD5.7 Million in Venture Financing 11
Vaccibody to Raise USD0.7 Million in Venture Financing 12
Vaccibody Raises US$0.97 Million In Venture Financing 13
Vaccibody Raises US$1 Million In Venture Financing 14
Partnerships 15
Vaccibody Enters into Agreement with Nektar Therapeutics 15
PharmaJet Partners with Vaccibody 16
Equity Offering 17
Vaccibody Raises USD26.2 Million in Private Placement of Shares 17
Vaccibody AS – Key Competitors 18
Vaccibody AS – Key Employees 19
Vaccibody AS – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Financial Announcements 21
Nov 09, 2017: Vaccibody: Quarterly report 3Q 2017 21
Aug 31, 2017: Vaccibody: Quarterly Report – 2017 Q2 23
May 10, 2017: Vaccibody: Quarterly Report – 2017 Q1 26
Mar 02, 2017: Vaccibody: Quarterly Report -2016 Q4 28
Corporate Communications 30
Dec 12, 2017: Vaccibody: Appointment of Agnete B. Fredriksen as President & CSO and Mette Husbyn as Chief Technical Officer 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Vaccibody AS, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Vaccibody AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vaccibody AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Vaccibody AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vaccibody AS, Deals By Therapy Area, 2012 to YTD 2018 8
Vaccibody AS, Medical Devices Deals, 2012 to YTD 2018 9
Vaccibody AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Vaccibody Raises USD5.7 Million in Venture Financing 11
Vaccibody to Raise USD0.7 Million in Venture Financing 12
Vaccibody Raises US$0.97 Million In Venture Financing 13
Vaccibody Raises US$1 Million In Venture Financing 14
Vaccibody Enters into Agreement with Nektar Therapeutics 15
PharmaJet Partners with Vaccibody 16
Vaccibody Raises USD26.2 Million in Private Placement of Shares 17
Vaccibody AS, Key Competitors 18
Vaccibody AS, Key Employees 19

List of Figures
Vaccibody AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Vaccibody AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Vaccibody AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Vaccibody AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Vaccibody AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vaccibody AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Vaccibody AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vaccibody AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Vaccibody AS, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Vaccibody AS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Jinsung TEC Co., Ltd. (036890):企業概要、財務及び戦略的SWOT分析
    Summary Jinsung TEC Co., Ltd. (Jinsung TEC) is a construction equipment manufacturing company. The company designs and manufactures heavy construction equipment parts and other products. Its products include track rollers, carrier rollers, front idlers, seal groups and sprocket. Jinsung TEC offers i …
  • Dar Al Arkan Real Estate Development Companyの企業概要及び財務/SWOT分析
    Dar Al Arkan Real Estate Development Company Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, pl …
  • Thomas Cook (India) Limited:企業概要・SWOT・財務分析
    Summary Canadean's "Thomas Cook (India) Limited : Travel and Tourism - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business d …
  • Bayer CropScience LP:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Bayer CropScience LP Mergers an …
  • Caprock Oil, Inc. (ROKO):企業概要、財務及び戦略的SWOT分析
    Summary Caprock Oil, Inc. (Caprock), formerly Stratum Holdings, Inc., is an oil and gas exploration company. The company provides exploration and production of oil and gas. Its oil and gas producing properties are majority owned and company operated; and they consist of conventional fields in the so …
  • TYRX, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' TYRX, Inc. Mergers and Acquisit …
  • Sysmex Corp (6869):企業のM&A・提携動向(医療機器分野)
    Summary Sysmex Corporation (Sysmex) is a supplier of medical devices. It researches, develops, manufactures and sells instruments, reagents, and software applications that facilitate health checkups, treatment and disease management. The company offers diagnostic instruments, reagents and laboratory …
  • ReGenX Biosciences, LLC(製薬・医療分野):企業M&A動向
    Summary ReGenX Biosciences, LLC (ReGenX) is a biopharmaceutical company. The company develops and offers therapeutics for various diseases. Its products include NAV, AAV plasmids, AAV vector reporter systems and custom AAV vectors. ReGenX’s NAV is a gene delivery technology, which include proprietar …
  • AbCheck s.r.o.(製薬・医療分野):企業M&A動向
    Summary AbCheck s.r.o. (AbCheck) is a biotechnology company. The company provides human antibody discovery, research, and generation services. Its technologies include Absieve, AbAccel, and AbCheck. AbCheck’s Absieve is an antibody discovery technology that offers proprietary phage display libraries …
  • Swisscom AG:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Swisscom AG Mergers and Acquisi …
  • Chelyabenergosbyt (CLSB):企業の財務及び戦略的SWOT分析
    Summary Chelyabenergosbyt, a subsidiary of RAO “UES of Russia” is an electric distribution company that provides utility services. The company offers services such as replacement of meters and current transformers; installation and reconstruction of electric power metering measuring complex; providi …
  • Banco de Sabadell, S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Banco de Sabadell, S.A. Mergers …
  • FX Energy, Inc.:企業のM&A・提携動向(石油・ガス分野)
    Summary FX Energy, Inc. (FX Energy), a subsidiary of Orlen Upstream Sp. z o.o. is an oil and gas company that explores, develops and produces oil and gas properties. The company's project areas include poland, fences area, block 287 concession area, northwest concession area, Kuton concession area, …
  • KAHR medical Ltd.(製薬・医療分野):企業M&A動向
    Summary KAHR medical Ltd. (KAHR) is a pharmaceutical company. The company develops fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its products include KAHR-101, KAHR-102, and KAHR-103. Its KAHR-101 is a fusion-protein used for the treatment in animal disease mode …
  • Digital Chocolate, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Digital Chocolate, Inc. Mergers …
  • Trafford Resources Limited (TRF):企業概要、財務及び戦略的SWOT分析
    Summary Trafford Resources Limited (Trafford) is a mineral exploration company. The company acquires, explores and develops iron oxide, copper, gold and uranium deposits in Australia. Its projects include Eillcherry Hill, Twin Peaks and Moorarie, Jumbuck project, Curral de Pedra and Lynas Find. Traf …
  • Cancer Genetics Inc (CGIX):企業のM&A・提携動向(医療機器分野)
    Summary Cancer Genetics Inc (CGI) is a pharmaceutical company that provides diagnostics products and services in oncology areas. The company offers products such as CGH Microarrays, Next-Generation Sequencing and DNA-FISH Probes. Its oncology tests and laboratory services offer critical genomic info …
  • Park Elektrik Madencilik Sanayi Ve Tas Ticaret A.S. (PRKME):企業財務及び戦略的SWOT分析
    Summary Park Elektrik Madencilik Sanayi Ve Tas Ticaret A.S. (Park Elektrik) is an energy utility provider that generates electricity. The company builds cogeneration energy plants for electricity, energy and vapor generation and establishes power stations for the generation and distribution of elect …
  • Keller Group plc:企業の戦略・SWOT・財務分析
    SummaryKeller Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findin …
  • EMD Serono, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' EMD Serono, Inc. Mergers and Ac …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆